NCT07804147

Brief Summary

This prospective study aims to compare combined breast ultrasound (US) and digital mammography (DM) with digital breast tomosynthesis (DBT) in the evaluation and reclassification of BI-RADS 3 (probably benign) breast lesions. The study will include 30 female patients with non-calcified breast lesions initially classified as BI-RADS 3 on digital mammography. Patients will undergo complementary targeted breast ultrasound and DBT. The imaging findings will be assessed separately and then integrated to determine the final BI-RADS classification. The study will evaluate whether DBT and combined US with DM can improve characterization and reclassification of BI-RADS 3 lesions, potentially reducing unnecessary short-interval follow-up while identifying lesions requiring further assessment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
4mo left

Started Jul 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jul 2026Feb 2027

Study Start

First participant enrolled

July 12, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 27, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 4, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

September 4, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

August 27, 2026

Last Update Submit

September 3, 2026

Conditions

Keywords

breastdense breastprobably benign breast lesionsBIRADs 3breast lesions reassessment

Outcome Measures

Primary Outcomes (1)

  • Change in BI-RADS classification of breast lesions

    The proportion of initially BI-RADS 3 breast lesions that are reclassified following assessment with digital breast tomosynthesis and complementary breast ultrasound, including downgrading to BI-RADS 2 or upgrading to a higher BI-RADS category based on imaging findings.

    through study completion, an average of 1 year

Study Arms (1)

BI-RADS 3 Breast Lesion Cohort

Female patients with at least one non-calcified breast lesion initially classified as BI-RADS 3 (probably benign) on digital mammography. Participants undergo complementary targeted breast ultrasound and digital breast tomosynthesis for evaluation and reclassification of the lesion.

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of 30 female patients presenting with at least one non-calcified breast lesion initially classified as BI-RADS 3 (probably benign) on standard 2D digital mammography. Patients with breast densities B, C, or D will be included, with particular consideration of dense breasts (C and D). All eligible participants will undergo complementary targeted breast ultrasound and digital breast tomosynthesis for lesion evaluation and BI-RADS reclassification.

You may qualify if:

  • \- Radiological classification: Patients with at least one non-calcified breast lesion initially classified as BI-RADS 3 (probably benign) on standard 2D digital mammography.
  • \- Breast density: Patients with breast densities B, C, or D are eligible, with particular consideration of dense breasts (C and D).

You may not qualify if:

  • Suspicious imaging features:
  • Patients with any lesion demonstrating BI-RADS 4 or 5 characteristics, including spiculated margins, fine linear branching calcifications, or architectural distortion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Sohag University

Sohag, Sohag Governorate, 0000, Egypt

Location

Study Officials

  • Mohamad Zaki Ali, Professor

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Radiology resident

Study Record Dates

First Submitted

August 27, 2026

First Posted

September 4, 2026

Study Start

July 12, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

September 4, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because no individual participant data sharing plan has been established for this study. Study data will be used for the purposes of the research and statistical analysis described in the study protocol.

Locations